Description

10mg starter kit includes

10mg of Tirzepatide (one months worth)

Reusable Epi Pen

epi pen needles

bacteriostatic water

glass cartridge for epi pen

needles for reconstitution

alcohol wipes

Tirzepatide (Dual GIP/GLP-1 Agonist) – 60 mg Kit
Includes bacteriostatic water and sterile needles for reconstitution

Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist designed to support weight management, appetite control, and glycemic regulation. By targeting both incretin pathways, Tirzepatide enhances insulin sensitivity, reduces food intake, and slows gastric emptying, making it highly effective in metabolic optimization protocols.

Clinical studies have demonstrated significant weight reduction and improved blood glucose control, with a structured titration approach improving tolerability.

This educational protocol outlines a once-weekly subcutaneous dosing strategy using a practical dilution for accurate measurement.

Kit Includes:

Tirzepatide 60 mg (lyophilized powder)
Bacteriostatic Water (for reconstitution)
Sterile needles/syringes

Reconstitute:
Add 3.0 mL bacteriostatic water → ~20 mg/mL (20,000 mcg/mL) concentration

Typical Weekly Protocol (Titration):

Week 1–4: 2.5 mg once weekly
Week 5–8: 5 mg once weekly
Week 9–12: 7.5 mg once weekly
Week 13+: 10–15 mg once weekly (based on tolerance and goals)

Easy Measuring:
At 20 mg/mL,

1 unit = 0.01 mL ≈ 200 mcg on a U-100 insulin syringe

Example:

2.5 mg dose ≈ 12.5 units
5 mg dose ≈ 25 units
10 mg dose ≈ 50 units
15 mg dose ≈ 75 units

Administration:

Subcutaneous injection (abdomen, thigh, or upper arm)
Once weekly, same day each week
Rotate injection sites for comfort

Storage:

Lyophilized vial: Store at −20 °C (−4 °F)
After reconstitution: Refrigerate at 2–8 °C (35.6–46.4 °F)
Do not freeze after mixing
Keep bacteriostatic water at room temperature before use

Note:
Tirzepatide is widely studied for obesity and type 2 diabetes management, showing strong results in fat loss, appetite suppression, and metabolic control. Common side effects may include nausea, reduced appetite, or mild gastrointestinal discomfort, particularly during dose escalation.